Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,400 | 65 | 62.8% |
| Gift | $1,414 | 2 | 37.0% |
| Education | $8.58 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| USWM, LLC | $1,465 | 4 | $0 (2023) |
| Alkermes, Inc. | $1,034 | 20 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $432.88 | 10 | $0 (2022) |
| ITI, Inc. | $302.03 | 7 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $286.40 | 10 | $0 (2023) |
| ABBVIE INC. | $99.34 | 6 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $94.47 | 6 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $37.85 | 2 | $0 (2022) |
| Lundbeck LLC | $32.22 | 1 | $0 (2022) |
| Almatica Pharma LLC | $22.16 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,653 | 9 | USWM, LLC ($1,465) |
| 2022 | $803.71 | 25 | Alkermes, Inc. ($251.36) |
| 2021 | $1,366 | 34 | Alkermes, Inc. ($616.49) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/20/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PSYCHIATRY | ||||||
| 06/23/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: CNS | ||||||
| 05/16/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: CNS | ||||||
| 03/08/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: CNS | ||||||
| 02/07/2023 | USWM, LLC | ZIMHI (Drug) | Gift | In-kind items and services | $706.92 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/07/2023 | USWM, LLC | ZIMHI (Drug) | Gift | In-kind items and services | $706.92 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/01/2023 | USWM, LLC | Lucemyra (Drug), ZIMHI | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Psychiatry/Psychology | ||||||
| 02/01/2023 | USWM, LLC | Lucemyra (Drug), ZIMHI | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Psychiatry/Psychology | ||||||
| 01/11/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $112.23 | General |
| Category: CNS | ||||||
| 11/08/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $82.15 | General |
| Category: CNS | ||||||
| 10/20/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $113.09 | General |
| Category: Neuroscience | ||||||
| 09/21/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: PSYCHIATRY | ||||||
| 08/18/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $119.77 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $119.01 | General |
| Category: CNS | ||||||
| 04/07/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: PSYCHIATRY | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Neuroscience | ||||||
| 04/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: CNS | ||||||
| 03/23/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: CNS | ||||||
| 03/17/2022 | Almatica Pharma LLC | GRALISE (Drug), SERTRALINE HCL, LOREEV XR | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 03/17/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 21 | 75 | $15,750 | $3,543 |
| 2021 | 4 | 79 | 186 | $52,111 | $11,128 |
| 2020 | 3 | 41 | 43 | $20,500 | $3,129 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Office | 2022 | 21 | 75 | $15,750 | $3,543 | 22.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 120 | $25,200 | $5,746 | 22.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 24 | 24 | $18,550 | $2,730 | 14.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 19 | 24 | $8,027 | $2,319 | 28.9% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 17 | 18 | $333.72 | $333.72 | 100.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $13,500 | $1,503 | 11.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 14 | $4,900 | $978.50 | 20.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $2,100 | $647.90 | 30.9% |
About Anthony Kimani
Anthony Kimani is a Psychiatric/Mental Health healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1295370401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony Kimani has received a total of $3,823 in payments from pharmaceutical and medical device companies, with $1,653 received in 2023. These payments were reported across 68 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,400).
As a Medicare-enrolled provider, Kimani has provided services to 141 Medicare beneficiaries, totaling 304 services with total Medicare billing of $17,801. Data is available for 3 years (2020–2022), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Mesa, AZ
- Active Since 11/12/2019
- Last Updated 05/24/2022
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1295370401
Products in Payments
- ZIMHI (Drug) $1,414
- LYBALVI (Drug) $457.17
- ARISTADA (Drug) $448.52
- CAPLYTA (Drug) $302.03
- SPRAVATO (Drug) $245.79
- INVEGA SUSTENNA (Drug) $187.09
- ABILIFY MAINTENA (Drug) $184.80
- VIVITROL (Drug) $124.83
- VRAYLAR (Drug) $99.34
- LATUDA (Drug) $94.47
- REXULTI (Drug) $87.92
- Lucemyra (Drug) $51.10
- ABILIFY MYCITE (Drug) $45.90
- HETLIOZ (Drug) $37.85
- GRALISE (Drug) $22.16
- INGREZZA (Drug) $16.33
- Vivitrol (Drug) $3.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Mesa
Ms. Gail Ziv, Psynp, PSYNP
Psychiatric/Mental Health — Payments: $25,633
Angela Stuff, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $20,880
Dr. Richard Beals, Dnp, Pmhnp, DNP, PMHNP
Psychiatric/Mental Health — Payments: $8,498
Yujun Lao
Psychiatric/Mental Health — Payments: $7,289
Ana Williams, Np, NP
Psychiatric/Mental Health — Payments: $5,096
Melanie Laub, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $3,862